Posted by Michael Wonder on 05 Jul 2022
NICE recommends three more treatments for atopic dermatitis
30 June 2022 - Doctors now have three more prescribing options for patients with severe atopic dermatitis who do not respond to current available therapies following the publication of final draft guidance from the National Institute for Health and Care Excellence.
NICE now recommends abrocitinib, upadacitinib, and tralokinumab as options for treating moderate to severe atopic dermatitis in adults and young people 12 years or over.
